STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATHA
  4. [EFFECT] LeonaBio, Inc. SEC Filing

[EFFECT] LeonaBio, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 1, 2026 4:00 P.M.
Form: S-1
CIK: 0001620463
Company Name: LeonaBio, Inc.
File Number: 333-292829

Source: View Original Filing on SEC EDGAR

Athira Pharma, Inc.

NASDAQ:ATHA

View ATHA Stock Overview →

ATHA Rankings

#5978 Ranked by Market Cap
N/A Ranked by Dividends

ATHA Latest News

Jan 9, 2026
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”
Dec 18, 2025
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million
Nov 6, 2025
Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
Sep 11, 2025
Athira Pharma Announces Reverse Stock Split
Aug 14, 2025
Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025

ATHA Latest SEC Filings

Apr 2, 2026
[EFFECT] LeonaBio, Inc. SEC Filing
Apr 1, 2026
[424B3] LeonaBio, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Apr 1, 2026
[424B3] LeonaBio, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Mar 31, 2026
[S-1/A] LeonaBio, Inc. Amends IPO Registration Statement
Mar 31, 2026
[S-1/A] LeonaBio, Inc. Amends IPO Registration Statement

ATHA Stock Data

26.62M
1.55M
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOTHELL